Skip to main content

Table 4 Breast cancer gene sets that are enriched in HFD microarray samples

From: Analysis of high fat diet induced genes during mammary gland development: identifying role players in poor prognosis of breast cancer

GENE SET NAME

SIZE

ES

NES

NOM

p-value

SMID_BREAST_CANCER_NORMAL_LIKE_UP

348

0.50

2.13

<0.001

POOLA_INVASIVE_BREAST_CANCER_UP

215

0.51

1.96

<0.001

BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP

142

0.46

1.91

<0.001

FINAK_BREAST_CANCER_SDPP_SIGNATURE

21

0.65

1.87

<0.001

FINETTI_BREAST_CANCER_KINOME_GREEN

15

0.75

1.86

<0.001

SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP

266

0.44

1.77

<0.001

SMID_BREAST_CANCER_LUMINAL_B_DN

412

0.36

1.69

<0.001

JOHNSTONE_PARVB_TARGETS_3_UP

306

0.34

1.64

<0.001

  1. Gene set enrichment analysis was preformed with microarray data from high fat and low fat diet as described in the Materials and Methods and 361 curated breast cancer gene sets on the Molecular Signatures Database, Broad Institute. In GSEA enrichment scores (ES) are calculated for each gene set using a Kolmogorov-Smirnov-style statistic. The ES indicates how strongly associated a gene set is with a given phenotype or not. GSEA generates nominal p-values (NOM p-value) using on a phenotype based permutation comparing ES with a null distribution. Normalized enrichment scores (NES) are adjusted enrichment scores based on the number of genes in each examined set. Gene sets with a nominal P-value (NOM p-value) of 0.001 or less and a normalized enrichment score (NES) of 1.5 or greater are shown. These data suggest that common genes are expressed in mammary fat pads from mice treated with HFD and invasive breast cancer.